Target intelligence / Profile preview

Pattern-recognition receptors sensing ALVAC vector components (PRRs (ALVAC))

Target
PRRs (ALVAC)
Molecular classification
Receptor, Enzyme, Signaling protein, Other
01

Overview

Pattern-recognition receptors (PRRs) sensing ALVAC vector components are a specialized group of innate immune sensors that detect the canarypox virus-based ALVAC vector. ALVAC is a highly attenuated, non-replicating poxvirus used as a delivery vehicle in various vaccine candidates, most notably in the RV144 HIV-1 vaccine trial (Rerks-Ngarm et al., 2009). Upon entry into host cells, ALVAC releases viral DNA and generates double-stranded RNA (dsRNA) intermediates, which are detected by cytoplasmic sensors such as cyclic GMP-AMP synthase (cGAS), Absent in Melanoma 2 (AIM2), and the NLRP3 inflammasome (Poli et al., 2013; Poli et al., 2017). The activation of these PRRs triggers downstream signaling pathways, specifically the cGAS-STING axis and inflammasome assembly, leading to the production of Type I interferons (IFN-α/β) and pro-inflammatory cytokines like IL-1β and IL-18. These sensing mechanisms are critical for the immunogenicity of ALVAC-based vaccines, as they provide the necessary danger signals or adjuvant effects required to prime adaptive immune responses. By stimulating these receptors, ALVAC promotes the maturation of dendritic cells and the subsequent activation of T-cells and B-cells. While primarily studied in the context of HIV prevention, ALVAC-sensing PRRs are also relevant in cancer immunotherapy, where the vector is used to deliver tumor-associated antigens. Understanding the specific PRRs involved allows for the rational design of more effective viral vectors and adjuvants that can precisely modulate the innate immune environment to achieve protective immunity.

Other names
ALVAC-sensing PRRsInnate immune sensors of canarypox virusPoxvirus-sensing receptorscGAS-STING and AIM2 sensing of ALVAC
02

Mechanism of action

Agonism of innate immune sensors (cGAS, AIM2, TLR3, NLRP3) to induce pro-inflammatory cytokines and Type I interferons, enhancing adaptive immune responses.

03

Biological functions

Immune responseSignal transductionCytokine productionInflammationCell death
04

Disease associations

InfectionCancer
05

Safety considerations

Excessive systemic inflammationInjection site reactionsPotential for auto-inflammatory responsesVector-induced reactogenicity
06

Interacting drugs

ALVAC (Canarypox virus vector)

5 more in the full profile.

07

Biomarkers

Interferon-alpha (IFN-α)Interleukin-1 beta (IL-1β)Interleukin-18 (IL-18)CXCL10 (IP-10)STING activation markers

Beyond the preview

Go deeper on Pattern-recognition receptors sensing ALVAC vector components (PRRs (ALVAC)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pattern-recognition receptors sensing ALVAC vector components (PRRs (ALVAC)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call